Collabrity

For early-stage therapeutic biotech CEO's seeking top-tier yet affordable C-level executive support in fundraising and operations that will stay with you from inception to exit, Collabrity has innovated a leveraged strategic consulting model that is uniquely suited to the needs of our clients. C-level leadership and continuity for private therapeutic biotech company CEOs worldwide – I look forward to scheduling a time soon to further explore the exceptional value that Collabrity would bring to your fundraising efforts and operations. Our DNA is from “inside the tent”. We see your challenges from the perspective of CFOs, CBOs, and COOs - and CXO combinations thereof – because those have been our roles. We have spent the bulk of our careers on senior leadership teams as employees of therapeutic biotech companies. Our imprinting experiences were not in consulting, auditing, or investment banking. While our approach may be consultative and our hours less than full-time according to your needs, we can be the corner office partner of CEOs - because our executive suite offices were always a short walk away. Executive quality standards. We come from listed companies, biotech unicorns, and companies backed by top-tier life sciences venture capital firms. We bring to our clients best-in-class analytics, practices, and performance based on executive experience. Yet we are affordable because we are leveraged. As executives, we have spent our careers forming, leading and monitoring G&A and R&D teams to efficiently perform the work of turning transformative research insights into FDA-approved therapies that serve patients. Securities are offered through Finalis Securities LLC Member FINRA / SIPC. Collabrity is not a registered broker-dealer, and Finalis Securities LLC and Collabrity are separate, unaffiliated entities.